XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://nckpharma.com/nmes-and-blas-approved-by-usfda-in-2014/20%Monthly2015-01-03 16:53
https://nckpharma.com/fda-approves-novo-nordisk-obesity-drug-saxenda/20%Monthly2014-12-30 10:38
https://nckpharma.com/glenmark-positive-on-gr-17536/20%Monthly2014-12-30 10:16
https://nckpharma.com/indian-biosimilar-market-size/20%Monthly2014-12-29 12:02
https://nckpharma.com/torrents-strategic-alliance-with-reliance-life-science-for-biosimilars/20%Monthly2014-12-27 10:12
https://nckpharma.com/fulford-india-divests-its-consumer-care-products-business-to-bayer-pharma/20%Monthly2014-12-26 09:34
https://nckpharma.com/claris-lifesciences-confirms-patent-challenge-for-its-generic-version-of-propofol-in-usa/20%Monthly2014-12-26 07:50
https://nckpharma.com/insight-on-usfda-biosimilar-application-of-pegfilgrastim/20%Monthly2015-01-08 04:40
https://nckpharma.com/viekira-pak-abbvie-hepatitis-c-drug-is-approved-by-usfda/20%Monthly2014-12-23 16:02
https://nckpharma.com/lilly-and-adocia-announce-alliance-to-co-develop-ultra-rapid-insulin-based-on-biochaperone-technology/20%Monthly2014-12-23 11:23
https://nckpharma.com/lilly-announces-diabetes-research-partnership-with-university-of-surrey/20%Monthly2014-12-23 10:53
https://nckpharma.com/usfda-approved-rapivab-peramivir-to-treat-influenza-infection-in-adults/20%Monthly2014-12-23 12:00
https://nckpharma.com/fda-approves-lynparza-to-treat-advanced-ovarian-cancer/20%Monthly2014-12-20 18:05
https://nckpharma.com/amarantus-submits-orphan-drug-designation-application-with-product-candidate-manf/20%Monthly2014-12-20 18:04
https://nckpharma.com/panacea-biotech-signs-strategic-alliance-with-rising-pharma/20%Monthly2014-12-20 17:43
https://nckpharma.com/fda-approves-xtoro-to-treat-swimmers-ear/20%Monthly2014-12-20 17:36
https://nckpharma.com/novartis-cipla-patent-battle/20%Monthly2014-12-19 11:42
https://nckpharma.com/novartis-drug-signifor-gains-fda-approval-as-the-first-medication-to-treat-cushings-disease-a-serious-endocrine-disorder/20%Monthly2014-12-17 02:46
https://nckpharma.com/what-is-the-meaning-of-pts-and-ptr-in-pharma-marketing/20%Monthly2014-12-14 14:33
https://nckpharma.com/price-control-on-52-new-drugs/20%Monthly2014-12-13 11:14
https://nckpharma.com/sun-pharmas-acquisition-of-ranbaxy-why-how-roads-ahead/20%Monthly2014-12-12 10:19
https://nckpharma.com/lupin-launches-authorized-genericfor-celebrex-capsules/20%Monthly2014-12-12 02:39
https://nckpharma.com/us-fda-issues-warning-on-pfizers-geodon/20%Monthly2015-05-18 14:48
https://nckpharma.com/patents-vs-exclusivity-take-a-closer-look/20%Monthly2014-12-11 15:51
https://nckpharma.com/what-is-compulsory-licensing/20%Monthly2014-12-11 11:11
https://nckpharma.com/pfizers-strategic-initiative-to-expand-rare-disease-research/20%Monthly2014-12-11 05:23
https://nckpharma.com/amgens-xgeva-gets-us-fda-approval-to-treat-hypercalcemia-of-malignancy-refractory-to-bisphosphonate-therapy/20%Monthly2014-12-11 02:47
https://nckpharma.com/zydus-cadila-to-launch-the-biosimilar-of-adalimumab-in-india/20%Monthly2014-12-10 05:13
https://nckpharma.com/merck-to-acquire-cubist-for-8-4-billion-to-strengthen-antibiotic-pipeline/20%Monthly2014-12-09 02:58
https://nckpharma.com/pfizer-and-merck-kgaa-are-teaming-up-to-develop-a-new-tumor-treatment-product/20%Monthly2014-12-07 16:53
https://nckpharma.com/takeda-amyloidosis-therapy-granted-breakthrough-status-by-us-fda-2/20%Monthly2014-12-07 16:42
https://nckpharma.com/case-study-usfda-approval-of-amgen-leukemia-drug-blinatumomab/20%Monthly2014-12-05 02:51
https://nckpharma.com/what-is-risk-evaluation-and-mitigation-strategy-rems-what-its-significance-in-drug-regulatory-affairs/20%Monthly2016-09-26 09:39
https://nckpharma.com/cipla-meda-sued-apotex-to-enforce-allergy-drug-patents/20%Monthly2014-12-04 14:11
https://nckpharma.com/mylan-gilead-ink-deal-for-taf-based-hiv-drugs/20%Monthly2014-12-04 02:45
https://nckpharma.com/nippon-kayaku-has-launched-a-biosimilar-version-of-remicade/20%Monthly2014-12-04 02:30
https://nckpharma.com/top-10-biologic-sales-growth-yy-2012-2013/20%Monthly2014-12-03 15:53
https://nckpharma.com/ranbaxy-launches-indias-first-biosimilar-of-infliximab-drug-infimab/20%Monthly2014-12-03 17:06
https://nckpharma.com/az-and-lilly-to-proceed-with-bace-inhibitor-trial-in-alzheimers/20%Monthly2014-12-02 02:31
https://nckpharma.com/top-10-blockbuster-by-sales-worldwide-in-2013/20%Monthly2014-12-02 10:47
https://nckpharma.com/what-is-code-of-federal-regulations-cfr-from-pharmaceutical-regulatory-affairs-point-of-view/20%Monthly2014-12-02 14:41